Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says

Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says


Weight-loss drugs have become a hot topic as public heath authorities and pharmaceutical companies seek to find solutions to the growing global obesity epidemic.

Florian Gaertner | Photothek | Getty Images

An oral drug made by Pfizer causes a similar amount of weight loss as, and works quicker than, rival Novo Nordisk‘s blockbuster injection Ozempic, according to results from a phase two clinical trial released Monday.

The results were presented at a medical conference late last year. But JAMA Network only now is releasing the full peer-reviewed study.

Pfizer’s trial followed 411 adults with Type 2 diabetes who either took the company’s pill, danuglipron, twice a day or a placebo. 

Patients who took a 120-milligram version of danuglipron lost around 10 pounds over the course of 16 weeks, the study found.

That compares with a phase three clinical trial on Ozempic, which found that adults who took a 1-milligram version of the injection lost around 9.9 pounds on average over 30 weeks. Patients take that shot once a week. 

The results suggest danuglipron may be as effective for weight as Ozempic over a shorter period of time. 

Pfizer’s drug also could offer an advantage as an oral treatment option rather than a frequent injection.

Both danuglipron and Ozempic are part of a class of drugs called glucagon-like peptide-1 antagonists.

They mimic a hormone produced in the gut called GLP-1, which signals to the brain when a person is full. 

The drugs can also help people manage Type 2 diabetes because they encourage insulin release from the pancreas, lowering blood sugar levels.

New York-based Pfizer is the latest pharmaceutical company to dip into the blockbuster weight loss drug market. 

Novo Nordisk’s Ozempic and Wegovy catapulted to the national spotlight in recent years for being weight loss “miracles.”

Hollywood celebrities, social media influencers, and billionaire tech mogul Elon Musk have reportedly used the popular injections to get rid of unwanted weight. 

But experts say the medicines may further perpetuate a dangerous diet culture that idealizes weight loss and thinness.

Some patients who stop taking the drugs also complain about a weight rebound that is difficult to control.

More than 2 in 5 adults have obesity, according to the National Institutes of Health. About 1 in 11 adults have severe obesity.



Source

Walmart pauses H-1B visas for job candidates as Trump hikes fees
Business

Walmart pauses H-1B visas for job candidates as Trump hikes fees

A Walmart store is shown in Oceanside, California, on May 15, 2025. Mike Blake | Reuters Walmart is pausing the hiring of job candidates who need H-1B visas to work in the U.S., according to a person familiar with the decision, an example of the ways the Trump administration’s immigration policies are shaping corporate strategy. […]

Read More
NHL strikes first-ever deal with prediction markets Kalshi and Polymarket
Business

NHL strikes first-ever deal with prediction markets Kalshi and Polymarket

The National Hockey League said Wednesday it’s reached a multi-year licensing agreement with prediction markets Kalshi and Polymarket. More sports leagues may be coming soon. Tarek Mansour, Kalsh’si co-founder and CEO, told CNBC’s “Squawk Box” the deal marked a “seminal moment” for prediction markets and the company. “A league like the NHL partnering with us […]

Read More
GM plans to launch eyes-off driving, Google AI and other new in-vehicle tech by 2028
Business

GM plans to launch eyes-off driving, Google AI and other new in-vehicle tech by 2028

Mary Barra speaks onstage during WSJ’s Future of Everything 2025 at The Glasshouse on May 28, 2025 in New York City. Dia Dipasupil | Getty Images NEW YORK — General Motors is targeting a suite of new software initiatives for its vehicles over the next three years, including an in-vehicle artificial intelligence assistant from Google […]

Read More